Device Trial Radar · NCT07282067
Orthofix PhysioStim PEMF Ankle Fusion Retrospective
Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jan 23, 2025
Primary completion
Jun 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Orthofix Inc.Public (OFIX)
- Sponsor type
- Industry
- First posted
- Dec 15, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 23 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study examines the effect of using the PhysioStim bone growth stimulator on subjects undergoing treatment for ankle and hindfoot fusion surgery.
Conditions
- Ankle Fusion
- Hindfoot Arthrodesis
- Ankle Arthrodesis
- Tibiotalar Arthrodesis
Interventions
Pulsed electromagnetic field (PEMF) stimulationDevice
Subjects treated with PEMF with be directed to use the device for 3 hours per day, up to 6 months or until no longer needed.
ControlOther
Control (no PEMF)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Radiographic fusion rate at 6 months post treatmentTime frame: 6 months from the start of treatment
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Arizona Foot Health
Phoenix, Arizona
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.